SLC5A2 and type 2 diabetes mellitus: The purpose of this study was to evaluate the long-term safety and efficacy of three SGLT-2 inhibitors (empagliflozin, dapagliflozin, and canagliflozin) administered to Calabrian patients with T2DM, attending our endocrinology/diabetology outpatient clinics.